China’s NMPA Approves Sanofi’s Rare Haematologic Disease Treatments
Wedoany.com Report-Dec.13, China's National Medical Products Administration has approved two Sanofi...
EU Inches Closer to New Pharma Legislation Amid Competitiveness Drive
Wedoany.com Report-Dec.13, European Union legislators have reached a provisional agreement on a revi...
EU Committee Backs Extending Use of Lilly’s Diabetes Drug for Children Aged 10 and Above
Wedoany.com Report-Dec.13, The European Medicines Agency's Committee for Medicinal Products for Hum...
UK Slashes 2026 Drug Rebate Rate by One-Third to Win Back Pharma Sentiments
Wedoany.com Report-Dec.12, The UK Government has reduced the rebate rate for innovative medicines by...
Moderna Signs Deal Worth up to $503M With Nanexa
Wedoany.com Report-Dec.12, Moderna, the U.S.-based mRNA technology company, has signed a licensing a...
Novartis and UK-Based Relation Forge R&D Deal Worth up to $1.7bn
Wedoany.com Report-Dec.12, Novartis, the Swiss pharmaceutical company, has entered a strategic colla...
US FDA Expands Use of Gsk’s Blujepa as Treatment for Gonorrhea
Wedoany.com Report-Dec.12, The U.S. Food and Drug Administration announced on Thursday that it has a...
Health Canada Approves Biogen’s Zurzuvae for PPD Treatment
Wedoany.com Report-Dec.11, Biogen Canada Inc. has received a Notice of Compliance from Health Canada...
Eli Lilly Picks Alabama as Home to $6BN Orforglipron Manufacturing Facility
Wedoany.com Report-Dec.11, Eli Lilly and Company has selected Huntsville, Alabama, as the site for i...
Pfizer to Cut Over 200 Jobs in Switzerland to Reduce Costs
Wedoany.com Report-Dec.11, Pfizer plans to reduce its workforce in Switzerland by more than 200 posi...